Virginia Retirement Systems’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.98M Buy
75,882
+30,400
+67% +$1.17M 0.02% 424
2026
Q2
$1.66M Buy
45,482
+7,200
+19% +$227K 0.01% 586
2026
Q1
$1.07M Sell
38,282
-12,100
-24% -$397K 0.01% 560
2025
Q4
$1.89M Buy
50,382
+40,200
+395% +$1.32M 0.01% 434
2025
Q3
$281K Sell
10,182
-11,900
-54% -$410K ﹤0.01% 854
2025
Q2
$698K Buy
22,082
+100
+0.5% +$3.22K ﹤0.01% 678
2025
Q1
$730K Sell
21,982
-3,318
-13% -$119K 0.01% 649
2023
Q3
$829K Buy
25,300
+3,100
+14% +$108K 0.01% 558
2023
Q2
$781K Buy
22,200
+11,500
+107% +$397K 0.01% 619
2023
Q1
$349K Buy
10,700
+5,000
+88% +$228K ﹤0.01% 839
2022
Q4
$314K Buy
+5,700
New +$313K ﹤0.01% 950

Other funds holding HRMY

Virginia Retirement Systems's HRMY Position: Q3 2026 in Review

Virginia Retirement Systems increased its Harmony Biosciences (HRMY) stake by 67% in Q3 2026, buying an estimated $1.17M and bringing the position to 75,882 shares worth $2.98M. The position accounts for 0.02% of the portfolio, ranked #424.

Virginia Retirement Systems first reported a position in HRMY in Q4 2022 and has held it in 11 quarters since. 358 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Virginia Retirement Systems held 75,882 shares of Harmony Biosciences worth $2.98M as of Q3 2026.
  • Virginia Retirement Systems bought 30,400 Harmony Biosciences shares in Q3 2026, an estimated $1.17M.
  • Harmony Biosciences made up 0.02% of Virginia Retirement Systems's portfolio in Q3 2026, its #424 holding.
  • Virginia Retirement Systems first reported a position in Harmony Biosciences in Q4 2022 and has held it in 11 quarters since.
  • 358 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.